5Dixon PH,Weerasekera N,Linton KJ,et al.Heterozygous MDR3 missense mutation associated with intrahepatic cholestasis of pregnancy:Evidence for a defect in protein trafficking[J].Hum Mol Genet,2000,9(8):1209-1217.
6Reyes H,Simon FR.Intrahepatic cholestasis of pregnancy:An estrogen-related disease[J].Semin Liver Dis,1993,13(3):289-301.
8Paus TC,Schneider G,Van De Vondel P,et al.Diagnosis and therapy of intrahepatic cholestasis of pregnancy[J].Z Gastroenterol,2004,42(7):623-628.
9Laifer SA,Stiller RJ,Siddiqui DS,et al.Ursodeoxycholic acid for the treatment of intrahepatic cholestasis of pregnancy[J].J Matern Fetal Med,2001,10(2):131-135.
10Mazzella G,Nicola R,Francesco A,et al.Ursodeoxycholic acid administration in patients with cholestasis of pregnancy:Effects on primary bile acids in babies and mothers[J].Hepatology,2001,33(3):504-508.
5Zhou Y, Liao Z, He X. Epidemiology of drug-induced liver injury in China: a systematic analysis of the Chinese literature including 21, 789 patients[ J]. Eur J Gastroenterol Hepatol, 2013,25(7) :825-829.
6Kaplowitz N. Drug-induced liver disorders: implications for drugde- velopment and regulation [ J ]. Drug Safety,2001,24 (7) :483 - 490.
7The American Journal of GASTROENTEROLOGY. ACG Clinical Guideline: The Diagnosis and Management of Idiosyncratic Drug-ln- duced Liver Injury. 2014.
8Yuan L, Kaplowitz N. Mechanisms of druginduced liver injury [ J ]. Clin Liver Dis, 2013, 17(4) : 507-518.
